Arkos Global Advisors’s Medtronic MDT Stock Holding History

Arkos Global Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,906	Closed	-$253K	–	141
2024 Q1	$253K	Buy	+2,906	New	+$248K	0.04%	125

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arkos Global Advisors's MDT Position: Q2 2024 in Review

Arkos Global Advisors sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,906 shares — an estimated $253K sold.

Arkos Global Advisors first reported a position in MDT in Q1 2024 and held it in 1 quarter. The position peaked at $253K in Q1 2024. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

Arkos Global Advisors reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
Arkos Global Advisors sold 2,906 Medtronic shares in Q2 2024, an estimated $253K.
Arkos Global Advisors first reported a position in Medtronic in Q1 2024 and held it in 1 quarter.
Arkos Global Advisors's Medtronic position peaked at $253K in Q1 2024.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Arkos Global Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.